BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11433209)

  • 1. MR proton spectroscopy in patients with CNS involvement in Bourneville's disease.
    Tarasów E; Kubas B; Walecki J
    Med Sci Monit; 2001; 7(4):762-5. PubMed ID: 11433209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between 1H-MR spectroscopy and clinical manifestation with tuberous sclerosis complex.
    Matsuo N; Imamura A; Ito R; Sugawara K; Takahashi Y; Kondo N
    Neuropediatrics; 2007 Jun; 38(3):126-9. PubMed ID: 17985261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT; Law M; Naidich TP; Leeds NE
    J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.
    Mascalchi M; Brugnoli R; Guerrini L; Belli G; Nistri M; Politi LS; Gavazzi C; Lolli F; Argenti G; Villari N
    J Magn Reson Imaging; 2002 Nov; 16(5):532-7. PubMed ID: 12412029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual inversion recovery MRI helps identifying cortical tubers in tuberous sclerosis.
    Cotton F; Rambaud L; Hermier M
    Epilepsia; 2006 Jun; 47(6):1072-3. PubMed ID: 16822256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral tuberous sclerosis: MR imaging.
    Nixon JR; Houser OW; Gomez MR; Okazaki H
    Radiology; 1989 Mar; 170(3 Pt 1):869-73. PubMed ID: 2916045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
    Arana E; Martínez-Granados B; Marti-Bonmati L; Martínez-Bisbal MC; Gil A; Blasco C; Celda B
    Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
    Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
    Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
    Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
    Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios.
    Petrou M; Sundgren PC; Pang Y; Rohrer S; Foerster B; Chenevert TL
    Acad Radiol; 2007 Mar; 14(3):340-3. PubMed ID: 17307667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
    J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differences in the spectroscopy of the lesions of the remitting relapsing form of multiple sclerosis shown by magnetic resonance].
    Martínez-Bisbal MC; Celda B; Martí-Bonmat L; Casanova-Estruch B; Coret-Ferrer F
    Rev Neurol; 2002 May 1-15; 34(9):807-12. PubMed ID: 12134339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR spectroscopy in multiple sclerosis.
    De Stefano N; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():31S-35S. PubMed ID: 17425732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy reveals central neuroaxonal impairment in systemic sclerosis.
    Bertinotti L; Mortilla M; Conforti ML; Colangelo N; Nacci F; Del Rosso A; Fonda C; Casale R; Matucci-Cerinic M; Pignone A
    J Rheumatol; 2006 Mar; 33(3):546-51. PubMed ID: 16511924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile tuberous sclerosis changes in the brain: proton MR spectroscopy findings.
    Sener RN
    Comput Med Imaging Graph; 2000; 24(1):19-24. PubMed ID: 10739318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative study of MR T1 and T2 relaxation times and 1HMRS in gray matter of normal adult brain.
    Fan G; Wu Z; Pan S; Guo Q
    Chin Med J (Engl); 2003 Mar; 116(3):400-4. PubMed ID: 12781046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
    Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.